Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-14

Clinical Trial Update: Validation of RCC Predicting Model With Emulated-target Trial

View source ↗

Summary

This clinical trial update describes validation of a renal cell carcinoma prognostic model using an emulated-target trial approach, currently recruiting at Peki…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Peking University Third Hospital | Conditions: Renal Cell Carcinoma (Kidney Cancer), Renal Cell Carcinoma (RCC) | Status: RECRUITING